Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Current Period Unaudited)

v3.22.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2022
Sep. 30, 2021
Cash $ 54,405 $ 2,266,639
Inventory 1,197,568 1,093,765
Prepaid expense and other current assets 180,261 307,341
Total current assets 1,432,234 3,667,745
Long-term assets:    
Property and equipment, net 3,642 5,240
Other assets 3,500 3,500
Total long-term assets 7,142 8,740
Total assets 1,439,376 3,676,485
Current liabilities:    
Accounts payable 1,288,078 408,083
Accrued expense and other liabilities 156,329 319,464
Current portion of derivative liability 0 1,000,000
Total current liabilities 1,444,407 1,727,547
Long-term liabilities:    
Accrued interest 246,918 167,137
Derivative liability, net of current portion 1,207,475 1,207,475
Total long-term liabilities 3,054,393 2,974,612
Total liabilities 4,498,800 4,702,159
Commitments and contingencies
Stockholders’ deficit:    
Common stock, $0.001 par value, 800,000,000 shares authorized; 237,169,770 shares issued as of March 31, 2022 and September 30, 2021 and 237,069,770 and 236,719,770 shares outstanding as of March 31, 2022 and September 30, 2021 236,920 236,720
Additional paid-in capital 48,841,040 48,534,525
Accumulated deficit (52,137,384) (49,796,919)
Total stockholders’ deficit (3,059,424) (1,025,674)
Total liabilities and stockholders’ deficit 1,439,376 3,676,485
Series 1 Convertible Notes [Member]    
Long-term liabilities:    
Convertible notes 550,000 550,000
Series 2 Convertible Notes [Member]    
Long-term liabilities:    
Convertible notes $ 1,050,000 $ 1,050,000